Novel fluorescent substrates of the human P450 enzyme CYP2D6 are provided. Also provided are methods for their manufacture and use. These substrates are useful in assessing CYP2D6 enzyme activity and in selecting compounds which inhibit CYP2D6 enzyme activity and, in particular, for identifying potential adverse drug interactions which are mediated by inhibition of CYP2D6 enzyme activity.
Novel fluorescent substrates of the human P450 enzyme CYP2D6 are provided. Also provided are methods for their manufacture and use. These substrates are useful in assessing CYP2D6 enzyme activity and in selecting compounds which inhibit CYP2D6 enzyme activity and, in particular, for identifying potential adverse drug interactions which are mediated by inhibition of CYP2D6 enzyme activity.
[EN] STABILISATION<br/>[FR] STABILISATION
申请人:UNIV MONTFORT
公开号:WO2010010343A1
公开(公告)日:2010-01-28
A dried composition comprising a membrane-associated recombinant cytochrome P450 (CYP) enzyme, wherein the CYP enzyme is stable at 21 °C for a period of at least 10 days, and preferably for at least 3 months. A method of storing a recombinant membrane-associated CYP enzyme, the method comprising providing a recombinant membrane-associated CYP enzyme, freeze-drying the CYP enzyme, and storing the dried CYP enzyme at room temperature.